ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 (ASMB) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q1 2024

Type / Class
Equity / Common Stock, par value $0.001
Symbol
ASMB on Nasdaq
Shares outstanding
15,535,831
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 (ASMB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GILEAD SCIENCES, INC. 29% -3% 4,505,391 +104% GILEAD SCIENCES, INC. 08 Aug 2025

Institutional Holders of ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 (ASMB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q1 0 $0 -$7,090,883 0
2023 Q4 8,647,319 $7,090,909 -$888,258 $0.82 42
2023 Q3 9,538,435 $8,441,336 -$822,987 $0.88 32
2023 Q2 10,465,062 $12,032,628 -$1,413,281 $1.15 31
2023 Q1 12,058,487 $10,132,844 -$2,696,808 $0.84 37
2022 Q4 14,193,683 $18,446,999 -$3,479,618 $1.30 38
2022 Q3 16,595,417 $27,215,067 -$1,058,512 $1.64 47
2022 Q2 17,189,015 $36,094,086 -$3,856,015 $2.10 51
2022 Q1 19,078,839 $39,299,944 -$9,004,415 $2.06 52
2021 Q4 23,096,231 $53,810,453 -$9,786,082 $2.33 57
2021 Q3 22,706,616 $79,015,136 -$15,483,325 $3.48 61
2021 Q2 27,092,112 $105,110,485 -$6,950,361 $3.88 87
2021 Q1 27,158,674 $124,930,551 +$3,461,631 $4.60 102
2020 Q4 26,661,326 $161,302,039 -$148,788,454 $6.05 106
2020 Q3 30,096,975 $494,769,297 +$965,633 $16.44 115
2020 Q2 29,993,173 $700,372,173 +$25,372,004 $23.32 103
2020 Q1 28,961,280 $429,566,715 +$7,108,278 $14.83 96
2019 Q4 28,128,251 $575,504,046 +$162,191,719 $20.46 99
2019 Q3 20,717,323 $203,852,941 -$9,083,327 $9.83 96
2019 Q2 21,081,214 $285,953,531 -$38,445,831 $13.49 105
2019 Q1 22,086,821 $435,072,882 +$11,598,737 $19.69 100
2018 Q4 21,336,229 $482,552,988 -$22,408,761 $22.62 105
2018 Q3 21,451,389 $796,704,124 +$177,939,690 $37.14 110
2018 Q2 16,619,055 $651,643,809 +$19,143,017 $39.21 103
2018 Q1 16,057,360 $789,004,865 +$27,408,726 $49.14 105
2017 Q4 15,553,324 $703,758,442 +$144,330,948 $45.25 96
2017 Q3 12,365,961 $431,475,805 -$9,930,754 $34.92 71
2017 Q2 12,545,320 $258,622,356 +$12,681,076 $20.65 64
2017 Q1 11,915,179 $301,467,000 +$19,729,899 $25.49 49
2016 Q4 11,664,156 $140,277,170 +$7,379,773 $12.15 36
2016 Q3 11,111,633 $79,350,000 -$991,944 $7.21 35
2016 Q2 11,282,629 $61,880,000 -$5,130,215 $5.55 42
2016 Q1 12,398,866 $61,573,000 -$829,366 $5.02 45
2015 Q4 12,345,854 $92,315,823 -$1,081,570 $7.51 48
2015 Q3 12,381,895 $118,371,122 -$281,444 $9.56 50
2015 Q2 12,067,730 $232,422,915 +$27,421,764 $19.26 57
2015 Q1 10,760,000 $142,462,000 +$85,107,581 $13.24 31
2014 Q4 4,299,218 $33,460,000 +$10,957,571 $7.86 22
2014 Q3 1,641,550 $13,446,000 +$13,446,000 $8.19 19